On February 21, Ji Yong, deputy director of Medical Department of Shenzhen Cancer Hospital of Chinese Academy of Medical Sciences, Zhang Ying, deputy director of Nursing Department, and Dr. Yan Xinxin of GCP Center visited Shenzhen Cell Valley. Our chief scientist Professor Wang Jianxun, Deputy General manager Tang Xiaomeng, Assistant Chairman Fu Yuchen, Minister of Marketing Sun Rui, and medical expert Jia Haitao of Precision Medicine Department warmly received them.

Accompanied and explained by Fu Yuchen, Assistant chairman of the Board, the visiting guests visited the smart exhibition hall of Shenzhen Cell Valley, and had a preliminary understanding of the unique advantages of Cell Valley in the field of cell and gene therapy, including strategic planning, founding team, core technology retroviral vector preparation, and cell product production process.

At the symposium, chief scientist Professor Wang Jianxun warmly welcomed the arrival of Vice Minister Ji Yong and his delegation, and introduced the development history, core technology and future planning of Shenzhen Cell Valley in detail. As a major public service platform for Shenzhen biomedicine industry, Shenzhen Cell Valley has the leading industrial production technology of retroviral vector in China, and can provide the whole process service from antibody screening, viral vector construction to CAR T cell preparation. At present, Shenzhen Cell Valley has successfully prepared a number of GMP grade CAR T cell products to treat a variety of blood tumor patients, and the clinical treatment effect is remarkable.

Vice Minister Ji Yong shared the clinical experience and technical advantages of Shenzhen Cancer Hospital, Chinese Academy of Medical Sciences, in the field of cancer prevention and treatment. He pointed out that precision treatment of tumors is the future direction of development, and cell therapy technology has great potential in it. The two sides conducted in-depth discussions on the application prospect of cell therapy technology in cancer prevention and treatment, cooperation mode of clinical research and personnel training. Vice Minister Ji Yong expressed the hope that with the technical platform of Shenzhen Cell Valley, the application of cell therapy technology in tumor clinical treatment will be promoted and more treatment options will be provided to patients.

Professor Wang Jianxun said that Shenzhen Cell Valley will give full play to its technical advantages in the field of cell therapy, strengthen cooperation with cancer hospitals, jointly carry out clinical research projects, and accelerate the transformation and application of scientific research results. At the same time, Shenzhen Cell Valley will also provide technical support and talent training services for cancer hospitals to help improve the overall level of cancer prevention and treatment in Shenzhen.

This exchange visit has laid a solid foundation for the cooperation between the two sides in the field of cell therapy. In the future, Shenzhen Cell Valley will continue to strengthen cooperation with medical institutions, promote the innovation and development of cell therapy technology, and bring more hope to cancer patients.